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GABA transporters play an important but poorly
understood role in neuronal inhibition. They can
reverse, but this is widely thought to occur only
under pathological conditions. Here we use
a heterologous expression system to show
that the reversal potential of GAT-1 under phys-
iologically relevant conditions is near the nor-
mal resting potential of neurons and that rever-
sal can occur rapidly enough to release GABA
during simulated action potentials. We then
use paired recordings from cultured hippocam-
pal neurons and show thatGABAergic transmis-
sion is not prevented by four methods widely
used to block vesicular release. This nonvesic-
ular neurotransmission was potently blocked
by GAT-1 antagonists and was enhanced by
agents that increase cytosolic [GABA] or [Na+]
(whichwould increaseGAT-1 reversal).We con-
clude that GAT-1 regulates tonic inhibition by
clamping ambient [GABA] at a level high enough
to activate high-affinity GABAA receptors and
that transporter-mediated GABA release can
contribute to phasic inhibition.
INTRODUCTION
Many synaptic physiologists view GABA transporters as
always operating in uptake mode, continuously working
at their maximum rate of uptake, and being capable of
nearly completely eliminating all GABA from the extracel-
lular space. However, this view is not consistent with the
thermodynamics of transporters. Instead, it is well known
that transporters can reverse (Attwell et al., 1993; Cam-
mack et al., 1994; Levi and Raiteri, 1993; Lu and Hilge-
mann, 1999; O’Malley et al., 1992; Pin and Bockaert,
1989; Schwartz, 1987), there is indirect evidence that
they are near equilibrium (and thus relatively inactive)
under resting conditions (Richerson and Wu, 2003), andNethere is a theoretical limit to how much they can reduce
ambient [GABA] (Attwell et al., 1993; Cavelier et al.,
2005; Richerson and Wu, 2003).
It is widely believed that reversal of GABA transporters is
uncommon except under pathological conditions. How-
ever, there is theoretical and indirect experimental evi-
dence that the membrane potential at which GABA trans-
porters reverse is close to the normal resting potential of
neurons. For example, GAT-1 (the neuronal isoform of
the GABA transporter) can be induced to reverse in hippo-
campal cultures by a small depolarization of membrane
potential caused by 6 mM K+ (Wu et al., 2001) or by an
increase in cytosolic [GABA] caused by the anticonvulsant
vigabatrin (Richerson and Wu, 2003; Wu et al., 2001, 2003).
The reversal potential of an electrogenic transporter can be
calculated if its stoichiometry is known (Aronson et al.,
2003; Richerson and Wu, 2003). For GAT-1, which is be-
lieved to undergo coupled translocation of Na+, Cl, and
GABA in a ratio of 2:1:1 (Kanner and Schuldiner, 1987;
Lu and Hilgemann, 1999), the theoretical reversal poten-
tial is close to the normal resting potential of neurons
when ambient [GABA] is 0.1–0.4 mM (Attwell et al., 1993;
Richerson and Wu, 2003). If true, this is surprising because
it suggests that GAT-1 would stop taking up GABA even
though ambient [GABA] is high enough to activate high-
affinity GABAA receptors (Saxena and Macdonald, 1996),
and thus GAT-1 would not be capable of lowering ambient
[GABA] enough to eliminate tonic inhibition of neurons
expressing these receptors. Determining whether these
calculations of reversal potential are accurate is important
because it allows predictions about the behavior of GAT-1
and its role in synaptic and extrasynaptic inhibition.
Several groups have directly measured transporter cur-
rents to determine whether GAT-1 operates as predicted
by classical models (Cammack et al., 1994; Krause and
Schwarz, 2005; Lu and Hilgemann, 1999; Mager et al.,
1993). Using this approach, it has been verified that the
magnitude of GAT-1 transporter currents is altered in
response to changes in sodium, chloride, and GABA
gradients as would be predicted if GABA translocation is
coupled to 2 Na+ and 1 Cl (Lu and Hilgemann, 1999).
However, the methods used to make these measure-
ments were relatively insensitive, making it necessary touron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc. 851
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120 mM intracellular [Na+], 60 mM intracellular [Cl],
and/or 2 mM extracellular [GABA]) to increase the size of
transporter currents. It has not yet been possible to mea-
sure the reversal potential of GAT-1 using this approach
under physiological conditions. Recordings of transporter
current also do not directly measure GABA flux, and there
can be Na+ flux in the absence of GABA flux (i.e., un-
coupled current) (Cammack et al., 1994; Krause and
Schwarz, 2005). GABA flux has been measured directly
using biochemical and radioactive assays (Belhage
et al., 1993; Pin and Bockaert, 1989; Schwartz, 1982;
Turner and Goldin, 1989), but these assays of GABA
release do not allow reversal potential to be determined.
A variety of indirect methods have also been used to
determine how easily GAT-1 will reverse (Wu et al.,
2001, 2003, 2006), but these lack the experimental control
needed to quantify the reversal potential.
Here we describe an assay to measure the reversal
potential of a GABA transporter. One set of CHO cells
was transfected with GAT-1 (‘‘GAT-1 cells’’). Another set
of CHO cells was transfected with high-affinity GABAA
receptors (‘‘sniffer cells’’) and was used to detect GABA
release from the GAT-1 cells. Using this approach, we
demonstrate that GAT-1 behaves as predicted by classi-
cal models, reverses under physiological conditions, and
is more dynamic than commonly believed. We then used
paired recordings from hippocampal neurons in culture
to demonstrate that these results are relevant to normal
GAT-1 function. In this preparation, we found that IPSCs
still occur after blocking vesicular neurotransmission,
and this is due to GAT-1 reversal. Taken together, these
results indicate that GAT-1 plays an important role in reg-
ulation of tonic inhibition and identify a primitive form of
neurotransmission that can maintain phasic inhibition
when there is failure of vesicular neurotransmitter release.
RESULTS
Detection of GAT-1 Reversal with a Sniffer
Cell Assay
GABAA receptors that include the d subunit are highly sen-
sitive to low levels of GABA (EC50 0.2–0.4 mM) and have
relatively little desensitization (Bianchi et al., 2002; Saxena
and Macdonald, 1996). The d subunit is coexpressed with
a6 subunits in cerebellar neurons, where it plays an impor-
tant role in mediating tonic inhibition (Brickley et al., 2001).
We took advantage of the high affinity of d subunit-con-
taining GABAA receptors to measure transporter-medi-
ated GABA release using a functional assay. Patch-clamp
recordings were made in whole-cell voltage-clamp mode
(holding potential = 60 mV) from CHO cells transfected
with the a6, b3, and d subunits of the GABAA receptor.
In successfully transfected (green fluorescent protein
[GFP]-expressing) sniffer cells, bath application of GABA
at 0.1 mM induced a current (871 ± 82 pA; n = 5; ECl =
0 mV) (see Figure S1A available online) that was blocked
by bicuculline (50 mM) (24 ± 12 pA; n = 5). This current852 Neuron 56, 851–865, December 6, 2007 ª2007 Elsevier Incwas not induced in CHO cells that underwent the transfec-
tion procedure but did not express GFP (3 ± 5 pA; n = 5).
Patch-clamp recordings were also made from a sepa-
rate set of CHO cells transfected with GAT-1 cDNA. These
GAT-1 cells were lifted off their coverslip and positioned
so they were touching the surface of sniffer cells
(Figure 1A). For this first set of experiments, the electrode
(intracellular) solution used for recording from the GAT-1
cell contained 30 mM Na+, 30 mM Cl, and 5 mM
GABA, concentrations that were chosen to be higher
than physiological to increase the chance of reversal so
that we could determine whether our approach was fea-
sible. An example of a voltage-clamp recording from
a sniffer cell under these conditions is shown in Fig-
ure S1B. An inward current was induced in the sniffer
cell when the GAT-1 cell was voltage clamped at a poten-
tial of 60 mV, and this current increased when the mem-
brane potential of the GAT-1 cell was increased. The
response of the sniffer cell was dependent upon the prox-
imity of the GAT-1 cell, because the current induced in the
sniffer cell decreased when the two cells were moved
apart from each other, and increased when they were
brought back together (n = 6).
Progressively more depolarizing voltages applied to the
GAT-1 cell (80 mV to +40 mV) led to progressively larger
inward current in the sniffer cell (Figure 1B; 1002 ± 174
pA at +40 mV; n = 11). The response was blocked by bicu-
culline (50 mM; 8% ± 4% of control; n = 9; p < 0.001), indi-
cating that it was due to activation of GABAA receptors.
CHO cells do not contain synaptic vesicles or the vesicular
GABA transporter vGAT, so the response was not due to
vesicular GABA release. The response was also not cal-
cium dependent, since the sniffer cell response in Ringer
with 0 mM Ca2+ was 91% ± 11% of that in normal Ringer
(n = 9; p > 0.05). Instead, the inward current was blocked
by the GAT-1 antagonist SKF-89976a (40 mM; 4% ± 1% of
control; n = 8; p < 0.001). There was no response when
CHO cells were used that underwent the transfection
procedure for GAT-1 but did not express GFP (n = 5).
We conclude that the response in the sniffer cell was
due to activation of GABAA receptors by GABA released
from the GAT-1 cell via transporter reversal.
Previous experiments have measured reversal poten-
tials by directly recording transporter currents in cells
transfected with GAT-1 (Cammack et al., 1994; Lu and
Hilgemann, 1999). We found that approach to be much
less sensitive than measuring GABA release using the
sniffer cell assay. Whole-cell patch-clamp recordings
were made from GAT-1 cells using an electrode solution
containing 15 mM Na+, 10 mM Cl, and 2 mM GABA
(Figure 1C)—intracellular concentrations that have been
reported by others to occur in some adult mammalian
neurons (Otsuka et al., 1971; Rose, 2002; Rose and Ran-
som, 1997; Schwartz, 1987; Zhu et al., 2005). As GAT-1
cells were depolarized using a voltage-ramp protocol (Fig-
ure 1D, top panel), a large inward current developed
in neighboring sniffer cells (peak current 336 ± 46 pA,
n = 8; Figure 1D, middle panel, black trace). At the same.
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Release via GAT-1 Reversal
(A) Patch-clamp recordings were made from
two CHO cells, one transfected with the a6,
b3, and d subunits of the GABAA receptor
(sniffer cell) and the other with GAT-1 (GAT-1
cell). The concentrations of Na+, Cl, and
GABA were systematically controlled in the
inside and on the outside of the GAT-1 cell.
(B) Using the concentrations of substrate
shown in (A), hyperpolarization from 60 mV
to 80 mV led to a decrease in inward current
in the sniffer cell, whereas depolarization to
40, 0, and +40 mV led to a progressively
larger inward current. The current was due to
GABA release from GAT-1 reversal, because
it was blocked by bicuculline (50 mM) and
SKF-89976a (40 mM).
(C) Concentrations of Na+, Cl, and GABA
used for experiments in (D). These concentra-
tions of substrate are within a range reported
to occur in some CNS neurons (see text).
(D) The CHO cell assay detected reversal of
GAT-1 more sensitively than when transporter
currents were measured directly. (Top panel)
GAT-1cellswere depolarized witha ramp proto-
col. (Middle panel) GABA release was detected
as a large inward current (black trace) induced
in the sniffer cell in response to ramp depolariza-
tion of the GAT-1 cell. This current was blocked
by SKF-89976a (40 mM; blue trace). (Bottom
panel) There was not any measurable trans-
porter current in the GAT-1 cell, which would
have been detected as a change in whole-cell
current in the GAT-1 cell in response to SKF-
89976a (black trace, control; blue trace, SKF-
89976a). Dotted line in middle panel is 400
pA and in bottom panel is 0 pA.time, there was a leak current measured in GAT-1 cells
during the ramp protocol (Figure 1D, bottom panel, black
trace). SKF-89976a (40 mM) completely blocked the in-
ward current in sniffer cells (5% ± 4% of control; n = 8;
p < 0.001) (Figure 1D, middle panel, blue trace). However,
there was not a consistent effect of SKF-89976a on the
leak current in the GAT-1 cells (change in slope conduc-
tance of GAT-1 cells induced by SKF-89976a = 0.09 ±
0.10 nS; Figure 1D, bottom panel, blue trace; n = 6; p >
0.05). This indicates that the current mediated by GAT-1
is too small to be detected by directly recording from the
GAT-1 cell (consistent with previous reports, as discussed
above). However, GAT-1 reversal could be monitored indi-
rectly by detecting GABA efflux using our sniffer cell assay.
The Reversal Potential for GAT-1 Is Near Resting
Potential under Physiological Conditions
We next determined the minimum voltage at which GAT-1
reversal could be detected under the physiologically rele-
vant conditions used in the previous experiment. Whole-
cell voltage-clamp recordings were made from GAT-1
cells using the electrode solution with 15 mM Na+,
10 mM Cl, and 2 mM GABA and a bath solution withN151 mM Na+, 135 mM Cl, and 0.1 mM GABA. A slow
ramp depolarization was repeated three to six times,
and the mean sniffer cell current was plotted (Figure 2A,
black trace). A moving average was then calculated from
the mean current (Figure 2A, green trace). The voltage in
the GAT-1 cell at which an increase in inward current was
first detected in the sniffer cell (i.e., ambient [GABA] first be-
gan to rise) was estimated to be the reversal potential for
GAT-1. For the recording in Figure 2A, the reversal potential
measured using this method was 69.5 mV. For record-
ings from 12 cell pairs, the mean reversal potential under
these conditions was 67.1 ± 6.47 mV, which was close
to the theoretical reversal potential of 68.2 mV (see Ex-
perimental Procedures). Thus, as predicted, the reversal
potential of GAT-1 under these physiologically relevant
conditions is near the normal membrane potential of
many neurons. This may be surprising, because it indicates
that GAT-1 would be at equilibrium under resting condi-
tions, and there would be no GABA uptake, even when am-
bient [GABA] is near the normal level of around 0.1 mM (see
Discussion). As shown in Figure S1A and previously (Bian-
chi et al., 2002; Saxena and Macdonald, 1996), this [GABA]
is high enough to activate high-affinity GABAA receptors.euron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc. 853
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Is Near Resting Potential under Physio-
logical Conditions and Shifts as Pre-
dicted for a Stoichiometry of 2 Na+:1
Cl:1 GABA
(A) Method used to measure the reversal
potential of GAT-1. Shown is the current in-
duced in a sniffer cell (top panel, black trace;
average of six trials) in response to ramp depo-
larization (bottom panel) of a GAT-1 cell. A
moving average (green trace) was calculated
from the mean current. A horizontal line was
drawn through the flat portion of the trace,
and then a vertical line was drawn at the time
that the inward current first began to increase.
The intersection of the vertical line with the
voltage-clamp command was used to deter-
mine the reversal potential, which was
69.5 mV in this example.
(B) The reversal potential shifted to hyperpolar-
ized levels when cytosolic [Na+] increased.
Shown is the current induced in sniffer cells in
response to ramp depolarization of three differ-
ent GAT-1 cells in which the cytosolic [Na+]
ranged from 10 mM to 20 mM.
(C) Effect of cytosolic [Na+] on reversal potential.
(D) Effect of cytosolic [Cl] on reversal potential.
(E) Effect of cytosolic [GABA] on reversal potential.
For (C)–(E) the squares are the mean (±SEM) of the measured reversal potential, the numbers above each square are the number of cells recorded,
and the solid line is the theoretical reversal potential.Thus, GAT-1 would not normally be able to eliminate tonic
inhibition even in the absence of synaptic GABA release.
GABA Transport Remains Coupled
to 2 Na+ and 1 Cl
The uncoupled mode described for GAT-1 involves so-
dium flux in the absence of GABA transport (Krause and
Schwarz, 2005). However, it is not known whether GAT-1
can operate in an uncoupled mode in which GABA flux
occurs in the absence of Na+ and Cl transport, and there
have been no methods previously available to determine
whether this is true under near-physiological conditions.
If GABA transport is always coupled to Na+ and Cl,
then the equations for the driving force on the transporter
should accurately predict changes in the reversal potential
of GAT-1 in response to changes in the transmembrane
gradients for Na+, Cl, and GABA (Aronson et al., 2003;
Attwell et al., 1993; Richerson and Wu, 2003).
We measured the reversal potential of GAT-1 while sys-
tematically varying [Na+], [Cl], or [GABA] in the whole-cell
patch-clamp electrode solutions used to record from dif-
ferent cells. The reversal potential of GAT-1 shifted pro-
gressively to more negative values as intracellular [Na+]
increased (Figure 2B). The experimentally measured
reversal potential of GAT-1 shifted from 24.2 mV to
84.2 mV as intracellular [Na+] was changed from 5 mM
to 20 mM (Figure 2C). The change in reversal potential
was measured to be 99.7 mV per 10-fold change in
[Na+]i (calculated as the slope of the linear regression),
compared to the predicted value of 117.1 mV. The differ-854 Neuron 56, 851–865, December 6, 2007 ª2007 Elsevier Incence was due to a small divergence from the theoretical
prediction at 5 mM, which was likely due to instability of
the recording at higher membrane potentials.
Similar experiments were performed using different
concentrations of chloride in the pipette solution. There
was a shift in reversal potential of GAT-1 from 32.7 mV
to 92.2 mV as intracellular [Cl] was changed from
2 mM to 20 mM (Figure 2D). Note that the reversal poten-
tial is more steeply dependent on the sodium gradient
than the chloride gradient, since there are twice as many
Na+ ions transported per translocation cycle. Theoretical
calculations predict that there is a 58.5 mV shift in rever-
sal potential with a 10-fold change in the chloride gradient,
which was close to the experimentally measured value
of 58.7 mV.
Even though GABA carries no net charge, a change in
the GABA concentration gradient would be expected to
shift the reversal potential of GAT-1 if GABA transport is
obligately coupled to 2 Na+ and 1 Cl. As predicted,
a change in intracellular [GABA] from 0.5 mM to 2 mM
led to a shift in the experimentally measured reversal po-
tential of GAT-1 from 35.6 mV to 67.1 mV (Figure 2E).
The shift in reversal potential was found to be 50.7 mV
per 10-fold change in the GABA gradient, which was close
to the theoretical value of 58.5 mV.
Our sniffer cell assay only allowed us to measure GABA
efflux, and not influx, requiring that we extrapolate our
measurements to estimate the reversal potential. This
may have led to an error, but the close correlation with
the theoretical reversal potential suggests that the error.
Neuron
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we used were able to detect GABA release from the GAT-1
cell soon after it began to occur. If there was an error, our
approach provides an upper limit for the reversal potential,
making our finding of a low reversal potential even more
significant.
We cannot rule out the possibility that an uncoupled Na+
current (Krause and Schwarz, 2005) occurred in our exper-
iments, since our assay would not detect it. However, our
results do indicate that GAT-1 does not allow spontaneous
GABA efflux via a channel-like mode, as occurs with the
dopamine transporter in response to amphetamine (Kahlig
et al., 2005), and when GABA flux does occur it remains
coupled to 2 Na+ and 1 Cl when the substrates are
near physiological concentrations.
GAT-1 Operates Rapidly Enough to Reverse
during an Action Potential
We next examined how rapidly GAT-1 reverses. Record-
ings were made from CHO cells in voltage-clamp mode
Figure 3. GAT-1 Reverses during Simulated Action Potentials
(A) A single depolarizing 100 ms square wave pulse from 60 mV
to +70 mV induced a large response in a sniffer cell.
(B) Current was also induced in a sniffer cell by a train of 10 ms depola-
rizing pulses from60 mV to +70 mV (frequency 10 Hz; train duration 5 s).
(C) Simulated action potentials induced a response in a sniffer cell. The
command voltage for the GAT-1 cell was a waveform (inset) that simu-
lated a train of action potentials at a rate of 40 Hz. The resting potential
was 60 mV, peak voltage was +40 mV, and action potential duration
was 6 ms. The response in the sniffer cell was due to GABA release via
GAT-1 reversal, because it was blocked by both SKF-89976a (40 mM)
and bicuculline (50 mM).Nat a holding potential of 60 mV using an electrode solu-
tion containing 30 mM Na+, 30 mM Cl, and 5 mM GABA.
The bath solution contained 151 mM Na+, 135 mM Cl,
and no GABA. A large inward current was induced in
sniffer cells in response to a 100 ms depolarizing pulse
to +70 mV in GAT-1 cells (379 ± 71 pA; Figure 3A; n = 5).
A train of 10 ms pulses to +70 mV at 10 Hz also induced
an inward current, this time with a more gradual onset
(207 ± 48 pA; Figure 3B; n = 9).
Based on the data presented above, we considered
whether GAT-1 might reverse rapidly enough to release
GABA during an action potential. To test this hypothesis,
we simulated action potentials in CHO cells (which do
not generate action potentials on their own) by varying
the voltage command supplied to the amplifier using
a waveform that replicated action potentials previously
recorded from cultured rat neurons. In response to a train
of 200 simulated action potentials at a rate of 40 Hz, an in-
ward current was generated in sniffer cells (76 ± 13 pA;
Figure 3C; n = 12). This current was due to GABA release
via GAT-1 reversal since it was blocked by SKF-89976a
(40 mM; 1% ± 2% of control; n = 10; p < 0.001) and bicu-
culline (50 mM; 4% ± 3% of control; n = 8; p < 0.005)
(Figure 3C). Although the substrate gradients used were
not as close to physiological as in Figure 2A, a change in
the concentration gradients for substrate would not alter
the rapidity with which GAT-1 would reverse. Instead, it
would only alter the reversal potential, which we have
already shown is close to normal resting potential under
physiological conditions. Thus, these data indicate that
GAT-1 should operate rapidly enough to reverse and
release GABA during action potentials in neurons.
GAT-1 Can Mediate GABAergic Transmission
between Hippocampal Neurons
To determine whether GABA release due to GAT-1 rever-
sal can occur during action potentials in neurons, we
performed patch-clamp recordings from pairs of rat hip-
pocampal neurons grown in primary dissociated cell
culture. Unless otherwise noted, cultures were pretreated
with the GABA transaminase inhibitor vigabatrin to en-
hance transporter-mediated GABA release (Richerson
and Wu, 2003; Wu et al., 2001, 2003). In Ringer containing
2 mM Ca2+, electrical stimulation of presynaptic GABAer-
gic neurons led to an inhibitory postsynaptic current
(IPSC) that was blocked by bicuculline (50 mM; n = 8).
When [Ca2+]o was decreased to 0.2 mM and [Mg
2+]o
was increased to 10 mM, IPSCs were blocked in response
to single presynaptic action potentials (n = 12). However,
IPSCs could still be elicited in response to high-frequency
stimulation of 76% of GABAergic synapses (n = 34 of 45;
50 Hz stimulation for 9 s; Figure 4A). These IPSCs were
blocked by the GABAA receptor antagonists gabazine
(Figure 4A; 200–400 nM; 13% ± 4% of control; n = 14;
p < 0.001) and bicuculline (Figure S2A; 50 mM; 2% ± 1%
of control; n = 8; p < 0.005). Both antagonists also induced
a shift in baseline holding current (bicuculline: 292 ±
59 pA; gabazine: 81 ± 22 pA), consistent with blockadeeuron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc. 855
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trin (Overstreet and Westbrook, 2001; Wu et al., 2001,
2003). A postsynaptic response could also be elicited in
high Mg2+/low Ca2+ solution without pretreatment with
vigabatrin (Figure 4B), although not as frequently (48% of
GABAergic synapses; n = 15 of 31).
An increase in the ratio of Mg2+ to Ca2+ to 20:1 is widely
used to block vesicular release. Therefore, maintenance
of synaptic transmission with a Mg2+ to Ca2+ ratio of 50:1
Figure 4. GABAergic Synaptic Transmission Occurs between
Hippocampal Neurons in High Mg2+ (10 mM)/Low Ca2+
(0.2 mM) Ringer and Is Blocked by GAT-1 Antagonists
(A) Dual patch-clamp recordings from a pair of rat hippocampal neu-
rons in culture after pretreatment with vigabatrin (100 mM; 128 hr).
Shown are IPSCs in response to high-frequency presynaptic stimula-
tion (50 Hz for 9 s). The first trace was recorded in Ringer with 2 mM
Ca2+. The next three traces were made in high Mg2+/low Ca2+ Ringer.
The IPSCs were blocked by gabazine (400 nM).
(B) IPSCs could also be obtained in high Mg2+/low Ca2+ solution from
neurons that had not been treated with vigabatrin.
(C) IPSCs in high Mg2+/low Ca2+ Ringer were blocked by NO-711 (10mM).
Bars in (A)–(C) indicate time of presynaptic stimulation.
(D) Concentration/response curve for NO-711. Each data point repre-
sents seven to nine different neuron pairs in high Mg2+/low Ca2+ Ringer.
Solid line is a logistic fit (Microcal Origin). IC50 was 0.43 mM.
(E) Concentration/response curve for SFK-89976a. Each data point rep-
resents 8 to 13 different neuron pairs in high Mg2+/low Ca2+ Ringer. IC50
was 1.3 mM.
For (D) and (E), error bars are SEM.856 Neuron 56, 851–865, December 6, 2007 ª2007 Elsevier Incis consistent with the hypothesis that the IPSCs that
occurred were due to reversal of GABA transporters. In
support of this hypothesis, GABAergic IPSCs in high
Mg2+/low Ca2+ solution were blocked by two GAT-1-spe-
cific antagonists, NO-711 (5–50 mM; Figure 4C; n = 27) and
SKF-89976a (5–40 mM; Figure S2B; n = 56). The response
was blocked in a concentration-dependent manner (Fig-
ures 4D and 4E), with an IC50 for both drugs (SKF-
89976a, 1.3 mM; NO-711, 0.43 mM) near that reported
previously for blockade of GABA uptake (SKF-89976a,
0.2 mM [Yunger et al., 1984]; NO-711, 0.38 mM [Borden,
1996]). During whole-cell recordings, GAT-1 blockade in-
duces a shift in holding current that can either be inward
or outward, depending upon the recording conditions
(Richerson and Wu, 2003; Wu et al., 2003). The direction
and amplitude of this shift in tonic current was unrelated
to the ability of NO-711 and SKF-89976a to block IPSCs
in high Mg2+/low Ca2+ solution.
It is hard to explain why specific GAT-1 antagonists
would block IPSCs in high Mg2+/low Ca2+ solution other
than by blocking GAT-1 reversal. It is unlikely that there
was residual vesicular GABA release that was blocked
by SKF-89976a and NO-711, because we found that
IPSCs induced in normal calcium Ringer were not affected
by either agent (peak amplitudes: 89% ± 14% of control in
50 mM NO-711, n = 8, p > 0.05; 98% ± 7% of control in 40
mM SKF-89976a, n = 9, p > 0.05). Other investigators have
also seen either no effect or an increase in the amplitude
of vesicular IPSCs in response to GABA transporter
blockers, including GAT-1-selective antagonists (Dingle-
dine and Korn, 1985; Isaacson et al., 1993; Nusser and
Mody, 2002; Overstreet and Westbrook, 2003; Roepstorff
and Lambert, 1992; Thompson and Gahwiler, 1992).
To rule out the possibility that the IPSCs we observed in
high Mg2+/low Ca2+ solution were due to residual calcium
influx causing vesicular GABA release, we used pretreat-
ment with tetanus toxin as an alternative method to block
vesicular GABA release. Cultures were pretreated with 10
mg/ml of tetanus toxin for >24 hr (27.5 ± 0.5 hr), a concen-
tration one to ten times greater than that previously shown
to block GABAergic vesicular release (Albus and Haber-
mann, 1983; Pearce et al., 1983; Pin and Bockaert,
1989). This also did not completely block IPSCs, which
could still be elicited in response to high-frequency stimu-
lation (Figure 5A; n = 10). The response after tetanus toxin
treatment was blocked by bicuculline (Figure 5A; 50 mM;
1% ± 1% of control; n = 4; p < 0.01) and by SKF-89976a
(Figure 5A; 40 mM; 8% ± 8% of control; n = 5; p >
0.005). IPSCs were also seen in 11 neuron pairs pretreated
with 5 mg/ml tetanus toxin (28 ± 0.5 hr), and these were
also blocked by bicuculline (50 mM; n = 3) and SKF-
89976a (40 mM; n = 6).
Pin and Bockaert (1989) previously reported that GABA
release induced from cultured striatal neurons (measured
using HPLC) is not prevented by removal of extracellular
calcium, treatment with tetanus toxin, or both. Similar to
those results, we found that the combination of tetanus
toxin and high Mg2+/low Ca2+ solution did not block.
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(5–10 mg/ml; 28 ± 0.8 hr) in which IPSCs could be induced
in normal calcium solution, IPSCs could also be induced in
high Mg2+/low Ca2+ solution (Figure 5B). The waveform of
IPSCs in tetanus toxin-treated neurons was different in
Ringer with calcium than in high Mg2+/low Ca2+ solution,
with the former having a more rapid rise and a higher
peak response, but followed by a decay to a similar
steady-state amplitude as IPSCs in high Mg2+/low Ca2+
solution (Figure 5B; steady-state response in 2 mM
Ca2+ = 73 ± 23 pA; in 0.2 mM Ca2+ = 64 ± 9 pA; n = 6,
p > 0.05).
Concanamycin A inhibits the vesicular H+-ATPase and
causes collapse of the proton gradient needed to load
GABA into synaptic vesicles (Rossi et al., 2003). This agent
is commonly used to block synaptic transmission. After
pretreatment of hippocampal cultures with concanamycin
A (0.5 mM; 2 hr), vesicular GABA release could no longer be
induced by a-latrotoxin (Sudhof, 2001) (n = 9; Figures 6A
and 6B), indicating that synaptic vesicles were effectively
depleted of GABA. However, IPSCs could still be obtained
by high-frequency stimulation of presynaptic neurons
(n = 54). These IPSCs were mediated by reversal of
GABA transporters, because they were blocked by NO-
711 (10 mM; 12% ± 2% of control; n = 27/29; p < 0.001)
(Figure 6C). After concanamycin A, IPSCs also occurred
in neurons when recordings were made in high Mg2+/low
Ca2+ solution (n = 10) (Figure 6D). As was true after tetanus
toxin treatment, high Mg2+/low Ca2+ solution changed the
waveform of IPSCs after concanamycin A treatment.
Figure 5. GABAergic Synaptic Transmission Also Occurred
after Treatment with Tetanus Toxin, and Was Blocked by
GAT-1 Antagonists
(A) IPSC in a neuron pretreated with 10 mg/ml tetanus toxin (27 hr) and
vigabatrin (100 mM; 100 hr). The IPSC was blocked by bicuculline
(50 mM) and by SKF-89976a (40 mM). Recording was made in Ringer
with 2 mM Ca2+.
(B) IPSC in a neuron pretreated with 5 mg/ml tetanus toxin (30 hr) and
vigabatrin (100 mM; 124 hr). The IPSC was blocked by SKF-89976a
(40 mM) while recording in Ringer with 2 mM Ca2+. IPSCs could also
be elicited from this neuron in high Mg2+/low Ca2+ Ringer (last trace).
Bars, presynaptic stimulation.NeIf the IPSCs described above are due to GAT-1 reversal,
then they should be enhanced by an increase in the
outward driving force on the GABA transporter, such as
occurs with an increase in cytosolic [Na+] or [GABA]
(Richerson and Wu, 2003; Wu et al., 2006). Consistent
with this prediction, IPSCs were larger after treatment
with vigabatrin, which increases cytosolic [GABA] and aug-
ments transporter-mediated GABA release (Wu et al.,
2001, 2003). After treatment with vigabatrin (100 mM; 85 ±
6 hr), the amplitude of IPSCs was increased in high Mg2+/
low Ca2+ solution (589 ± 139 pC; n = 30) compared to
untreated neurons (292 ± 69 pC; n = 33; p < 0.05). The
enhancement by vigabatrin was unlikely to be due to en-
hancement of incompletely blocked vesicular neurotrans-
mission, since vigabatrin does not increase vesicular
GABA release (Overstreet and Westbrook, 2001; Wu
et al., 2003).
The magnitude of IPSCs in high Mg2+/low Ca2+ solution
increased with presynaptic firing rate. At firing rates less
Figure 6. GABAergic Synaptic Transmission Occurred after
Treatment with Concanamycin A, and Was Also Blocked by
GAT-1 Antagonists
(A) a-latrotoxin (0.6 nM) caused a large amount of vesicular GABA
release in control neurons.
(B) a-latrotoxin did not induce any vesicular release in neurons pre-
treated with concanamycin A (0.5 mM for 2 hr).
(C) IPSCs could still be induced in this neuron after pretreatment with
concanamycin A. The response was decreased by NO-711 (10 mM).
(D) IPSCs could also be elicited in high Mg2+/low Ca2+ Ringer after
pretreatment with concanamycin A. Bars, presynaptic stimulation.uron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc. 857
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synapses (n = 12). There was a small response at 20 Hz
(77 ± 37 pC), and this increased further at 50 Hz (720 ±
101 pC). Although there are several possible explanations
for this, it is consistent with an increase in driving force for
GABA transporter reversal, since intracellular [Na+] and
mean membrane potential would both increase in presyn-
aptic terminals with increasing firing rate.
Nonvesicular GABAergic Neurotransmission Can
Occur in the Absence of Extracellular Ca2+
The data described above from neurons support the con-
clusion that GAT-1 will reverse during action potentials.
However, in contrast to these findings we observed that
IPSCs only rarely occurred in Ringer with 0 mM Ca2+
with or without EGTA (n = 1 of >25 attempts). This was
not because GAT-1 is directly dependent on Ca2+ (see
above). Furthermore, IPSCs were blocked when cadmium
(0.2–1 mM) was added to high Mg2+/low Ca2+ solution
(n =9), as well as inhigh Mg2+/low Ca2+ solution with a com-
bination of u-conotoxin MVIIA (1 mM) and u-agatoxin IVA
(200 nM) (n = 7), calcium channel antagonists that potently
block IPSPs in rat hippocampal neurons (Poncer et al.,
2000). We considered the possibility that complete elimina-
tion of calcium influx prevents vesicular fusion more effec-
tively than the other methods used above. However, the
following experiments demonstrate that this was not the
case, but indicate instead that calcium influx augments,
but is not required for, GAT-1-mediated neurotransmission.
Recordings were made from pairs of cultured hippo-
campal neurons (naive to vigabatrin) in normal Ringer.
After identifying synaptically coupled pairs in which the
presynaptic neuron was GABAergic, the bath solution
was changed to Ringer containing 0 mM Ca2+, 1 mM
EGTA, and Anemone Toxin II (ATx). ATx delays inactiva-
tion of sodium channels, and as described previously
(Hartung and Rathmayer, 1985) this prolonged action
potentials (Figure 7A). ATx also caused neurons to burst
after they were stimulated by a train of depolarizing pulses
(Figure 7B) and to occasionally burst spontaneously
(Figure 7C, bottom trace). In one case, while recording in
Ringer with 0 mM Ca2+, 1 mM EGTA, and 5 nM ATx, we
observed a large current in the postsynaptic neuron
when the presynaptic GABAergic neuron spontaneously
burst (Figure 7C). To determine whether this could be
a nonvesicular GABAergic IPSC, we made paired record-
ings from synaptically coupled neurons in Ringer with
0 mM Ca2+, 1 mM EGTA, and 5 nM ATx. Bursts of action
potentials were induced in the presynaptic neuron by
stimulation at 50 Hz for 9–20 s. This led to inward currents
(Figure 7D) in 22 of 29 (76%) postsynaptic neurons (peak
current 206 ± 26 pA). These calcium-independent IPSCs
were due to GABA release, because they were blocked
by gabazine (Figure 7D). The peak amplitude of IPSCs in
gabazine was 7% ± 4% of that in zero calcium Ringer
(p < 0.005; n = 8). The GABA release was due to GAT-1 re-
versal, because the IPSCs were also blocked by SKF-
89976a (Figure 7E). The peak amplitude of IPSCs in858 Neuron 56, 851–865, December 6, 2007 ª2007 Elsevier IncSKF-89976a was 9% ± 4% of that in zero calcium Ringer
(p < 0.001; n = 11). It was not clear how much of the GABA
release was due to action potentials versus tonic depolar-
ization that sometimes followed the bursts. Either one
alone could induce release since IPSCs could begin dur-
ing bursts of action potentials (Figure 7C, vertical dashed
lines), could occur when there were bursts without tonic
depolarization (Figure 7B), or could be prolonged during
the tonic depolarization phase (Figure 7C). Pressure
microejection of 9 mM K+ could also induce bursting in
Ringer with 0 mM Ca2+, 1 mM EGTA, and 5 nM ATx (data
not shown). This was also associated with IPSCs that were
blocked by SKF-89976a (Figure 7F).
The enhancement of nonvesicular GABA release by ATx
described above is consistent with augmentation of Na+
influx during prolonged action potentials, which would
lead to a larger increase in cytosolic [Na+] and a greater
driving force for GAT-1 reversal.
Glutamate Transporters Do Not Reverse during
High-Frequency Firing
It was not possible to elicit nonvesicular glutamatergic
EPSCs. Patch-clamp recordings were made from 12 pairs
of neurons in Ringer with 2 mM Ca2+, 50 mM picrotoxin,
and 1 mM CGP-55845 (GABAB antagonist). Postsynaptic
responses obtained under these conditions were con-
firmed to be glutamatergic by blockade with CNQX
(10 mM). When recordings were made from these neurons
in high Mg2+/low Ca2+ solution, it was not possible to elicit
a response during high-frequency stimulation (50 Hz, 9 s),
supporting the conclusion that high Mg2+/low Ca2+
solution is effective in blocking vesicular fusion and also
indicating that the glutamate transporter does not reverse
under these conditions. These results are consistent with
the fact that glutamate transporters have a different stoi-
chiometry than GABA transporters and require a much
higher membrane potential to reverse (Richerson and
Wu, 2003; Wu et al., 2003; Zerangue and Kavanaugh,
1996). For this reason, it is predicted that glutamate trans-
porters should only reverse under pathological conditions
(Rossi et al., 2000).
DISCUSSION
The prevailing view of chemical synaptic transmission is
that it occurs solely due to fusion of synaptic vesicles
and that the only role of neurotransmitter transporters
under physiological conditions is to recover released
transmitter. Here we provide two lines of investigation
that support the conclusion that GABA transporters play
a more complex role.
Reversal Potential of GAT-1
The CHO cell assay we used to study GAT-1 reversal has
several advantages. It is highly sensitive for detecting
reversal of GABA transport, there is good control of mem-
brane potential and substrate concentrations on the two
sides of the membranes, and CHO cells do not have.
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sion Could Be Induced in the Absence of
Extracellular Ca2+ when Na+ Influx Was
Enhanced by ATx
(A) ATx prolongs action potentials. Recordings
were made in Ringer after treatment with 10 nM
and 50 nM ATx.
(B) ATx caused some hippocampal neurons to
burst in response to stimulation. This neuron
was exposed to 10 nM Atx and stimulated
with current injection (at bar).
(C) Simultaneous recording of two hippocam-
pal neurons in Ringer with 0 mM Ca2+, 1 mM
EGTA, and 5 nM ATx. The neuron in the bottom
trace (current clamp) was GABAergic and syn-
apsed onto the neuron in the top trace (voltage
clamp). ATx caused the GABAergic neuron to
burst spontaneously, and this was associated
with a large inward current in the postsynaptic
neuron. Note that the inward current began
during the burst (dashed lines) but continued
during the tonic depolarization that followed.
(D) Simultaneous recording from two neurons
in Ringer with 0 mM Ca2+, 1 mM EGTA, and
5 nM ATx. Stimulation (50 Hz, 9 s, at bars) of
the presynaptic GABAergic neuron (bottom
traces) induced IPSCs in the postsynaptic neu-
ron (top traces). The response was blocked by
gabazine (40 mm).
(E) In another pair of neurons recorded under
the same conditions, IPSCs were also blocked
by SKF-89976a (40 mm).
(F) Under the same conditions as in (D), pres-
sure microejection of 9 mM K+ (at bars) led to
a large inward current in this neuron. This stim-
ulus also caused bursting of neurons (data not
shown). The inward current was blocked by
SKF-89976a (40 mm).synaptic vesicles, so GAT-1-mediated GABA release can
be studied in isolation. The results clearly demonstrate
that when GABA translocation occurs it remains coupled
to 2 Na+ and 1 Cl and support our previous prediction
that under physiological conditions the reversal potential
of GAT-1 is near the resting potential of neurons (Richer-
son and Wu, 2003). There were not many assumptions
in making that prediction. The only parameters required
for calculation of reversal potential are the intracellular
and extracellular concentrations of Na+, Cl, and GABA
and the coupling ratio for GABA transport. Extracellular
[Na+] and [Cl] are known. Intracellular [Na+] has been
measured to be 5–15 mM in neurons at rest (Rose,
2002). Intracellular [Cl] is approximately 10 mM in many
adult neurons, as assessed by measuring the reversal
potential of GABAA receptor-mediated currents. The cou-
pling ratio of 2 Na+:1 Cl:1 GABA is widely accepted, and
our experiments verify that this holds over a physiological
range of substrate concentration. The only two parame-
ters for which the values might be questioned are intracel-Nlular and extracellular [GABA]. However, there are good
reasons to believe the values we used were realistic.
Brain extracellular [GABA] has been reported to be 0.1–
0.8 mM (Cavelier et al., 2005; Hagberg et al., 1985; Lerma
et al., 1986; Phillis et al., 1994; Tossman et al., 1986).
These measurements are likely to be accurate, because
there is tonic inhibition of many neurons, and an ambient
[GABA] this high would be needed to activate high-affinity
GABAA receptors that have an EC50 of 0.2–0.4 mM (Saxena
and Macdonald, 1996). Thus, our use of 0.1 mM for ambi-
ent [GABA] in our theoretical calculations and experimen-
tal protocol is reasonable.
A cytosolic [GABA] of 2 mM is also justified from the
literature. It has been reported that cytosolic [GABA]
ranges from 1 mM to 6 mM in mammalian neurons (Otsuka
et al., 1971) and 10 mM in horizontal cells of fish retina
(Schwartz, 1987). It is difficult to measure cytosolic
[GABA] in neurons, so it is easy to be skeptical about these
values. However, a value this high is consistent with re-
sults from magnetic resonance spectroscopy that haveeuron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc. 859
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be 1 mM (Rothman et al., 1993)—which would include
a contribution from many nonGABAergic neurons and
glia with a low [GABA]. Our use of 2 mM is also conserva-
tively low given the conclusion of Hell and Jahn (1998) that
cytosolic [GABA] is 5 mM or more since the Kd for the
vesicular GABA transporter vGAT is 10 mM.
A cytosolic [GABA] of at least 2 mM in GABAergic neu-
rons is also supported by the following logic. There is a sig-
nificant amount of tonic inhibition in slices and in culture
after vesicular GABA release is inhibited by zero calcium
solution, tetanus toxin, and/or H+-ATPase blockers (Ha-
mann et al., 2002; Rossi et al., 2003; Wu et al., 2001,
2003, 2006). Under these conditions, it can be assumed
that extracellular [GABA] is at least 0.1 mM, since [GABA]
would need to be this high for tonic inhibition to occur. It
can also be assumed that after blockade of synaptic
GABA release GAT-1 would be able to reach its equilib-
rium, and thus the reversal potential for GAT-1 would be
near the neuronal membrane potential. Therefore, the
steady-state equation for the reversal potential of GAT-1
can be solved for cytosolic [GABA], since we have good
estimates for all the other variables. If membrane poten-
tial = 60 mV, cytosolic [Na+] = 10 mM, cytosolic [Cl] =
10 mM, ambient [Na+] = 150 mM, ambient [Cl] =
135 mM, and ambient [GABA] = 0.1 mM, solving the equa-
tion (see below) at 37C gives a cytosolic [GABA] of
2.9 mM. Although this is an estimate, it provides assur-
ance that our use of 2 mM for cystosolic [GABA] is rea-
sonable and that previous estimates and measurements
of cytosolic [GABA] were relatively accurate. Intracellular
Figure 8. Theoretical Dependence of Ambient [GABA] on
Membrane Potential and Cytosolic [GABA]
Shown are calculations of ambient [GABA] when GAT-1 is at equilib-
rium (i.e., driving force = 0). At a membrane potential of 60 mV, there
will be no net transport of GABA when ambient [GABA] is between 0.04
mM and 0.3 mM for cytosolic [GABA] between 0.5 mM and 4 mM. These
levels of ambient GABA span a range that would induce tonic inhibition
of neurons expressing high-affinity GABAA receptors. Calculations
were made assuming intracellular and extracellular [Na+] and [Cl] of
150, 15, 135, and 10 mM, respectively.860 Neuron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc[Na+] may be slightly higher in some neurons, and cyto-
solic [GABA] might be slightly lower, but over a fairly
wide range the reversal potential would be relatively close
to the normal resting potential of many neurons.
Role of GAT-1 in Regulating the Level
of Tonic Inhibition
The data presented here have clear implications for regu-
lation of tonic inhibition. It is widely believed that the major
source of ambient GABA for tonic inhibition is spillover of
synaptic GABA. This belief stems in part from the assump-
tion that GABA transporters constantly operate in the for-
ward direction at their maximum rate, and therefore any
GABA that is present in the extracellular space must be
there because it escaped the synaptic cleft before it could
be scavenged by GAT-1. However, this is not a realistic
view of transporter function. Instead, the rate of GABA
reuptake is determined by the driving force on GABA
transporters, and this driving force will become smaller
as extracellular [GABA] decreases. Eventually the driving
force becomes zero when ambient [GABA] decreases to
the level at which GAT-1 is at equilibrium. We calculated
the ambient [GABA] at which GAT-1 is at equilibrium for
a neuron at four different levels of cytosolic GABA (Fig-
ure 8). The significance of these calculations is that
GAT-1 would not be able to reduce ambient [GABA] below
the values shown, even if there was no synaptic GABA
release. If ambient [GABA] fell below these equilibrium
values, GAT-1 would reverse to raise ambient [GABA] up
to the equilibrium values. The surprising conclusion is
that tonic inhibition does not exist simply because GABA
transporters are unable to keep up with synaptic GABA
release, leading to spillover, but instead because GAT-1
will not reduce ambient [GABA] below a level that is often
high enough for tonic inhibition to occur. This can explain
why the amount of tonic inhibition is relatively unaffected
by inhibition of vesicular GABA release (Hamann et al.,
2002; Rossi et al., 2003; Wu et al., 2006).
The anticonvulsants vigabatrin and gabapentin both
increase brain GABA levels (Petroff et al., 1996; Rothman
et al., 1993). This presumably includes an increase in neu-
ronal cytosolic [GABA], which Figure 8 predicts would shift
the setpoint for GAT-1 to a higher ambient [GABA]. This
can explain why both drugs increase tonic inhibition
(Cheng et al., 2006; Overstreet and Westbrook, 2001;
Wu et al., 2001).
Reversal of GAT-1 during Action Potentials
Our data from CHO cells indicate that GAT-1 can reverse
rapidly enough for GABA release to occur during action
potentials. In fact, there are several reasons why reversal
of GAT-1 might be less likely (or harder to detect) in our
CHO cells compared to real neurons in vivo. First, our
experiments were performed at room temperature, which
reduces the rate of transport compared to body tempera-
ture (Gonzales et al., 2007). Second, the distance between
GAT-1 cells and sniffer cells in our experiments was
greater than the normal distance between neurons at.
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distance for diffusion would have slowed and attenuated
the response. Third, in neurons the increase in intracellular
[Na+] during a train of action potentials, which can reach
35 mM or higher (Rose, 2002; Rose and Ransom, 1997),
would enhance GAT-1 reversal (Figure 2C), and this would
not occur in CHO cells since they do not express voltage-
dependent sodium channels. Therefore, the data from
CHO cells suggest that it would be surprising if GAT-1
did not reverse in neurons in response to high-frequency
firing.
Our data from hippocampal neurons demonstrate that
GAT-1 does reverse during high-frequency firing. These
data include the following. (1) IPSCs were not blocked
by tetanus toxin, concanamycin A, or high Mg2+/low
Ca2+ solution alone or in combination. (2) IPSCs occurred
in the absence of extracellular calcium when Na+ influx
was enhanced by ATx. (3) IPSCs under each of these con-
ditions were completely blocked by highly specific GAT-1
antagonists at low concentrations. (4) Nonvesicular IPSCs
were enhanced by vigabatrin, which increases nonvesicu-
lar GABA release but decreases vesicular neurotransmis-
sion (Overstreet and Westbrook, 2001; Wu et al., 2003). (5)
Similar results were not obtained at glutamatergic synap-
ses, consistent with a higher theoretical reversal potential
for glutamate transporters.
Our results indicate that extracellular calcium influences
GAT-1-mediated GABA release. This was not due to a di-
rect effect, since GAT-1 was unaffected by calcium in our
CHO cell assay. We propose the following model to
explain the effect of calcium. During an action potential,
GAT-1 reversal occurs due to both depolarization and
a rise in [Na+] within presynaptic terminals. The increase
in cytosolic [Na+] is due to (1) influx of Na+ via voltage-
dependent Na+ channels and (2) influx of Na+ via the
Na/Ca exchanger in the process of extrusion of Ca2+
that has entered the terminal via voltage-dependent
Ca2+ channels. This is consistent with previous work
showing that Na/Ca exchange makes a major contribution
to the rise of intracellular [Na+] during activity (Regehr,
1997). Our data demonstrate that lowering extracellular
Ca2+ reduces GAT-1-mediated GABA release, but this
can be overcome simply by enhancing Na+ influx via Na+
channels. Thus, nonvesicular IPSCs are sensitive to extra-
cellular Ca2+, but are not dependent on it.
The fact that GABAergic neurotransmission can occur
due to reversal of the GABA transporter may seem surpris-
ing, but there is abundant evidence that depolarization
induces transporter-mediated GABA release (Belhage
et al., 1993; Cammack et al., 1994; Gaspary et al., 1998;
Pin and Bockaert, 1989; Richerson and Wu, 2003;
Schwartz, 1982, 1987; Wu et al., 2001, 2003). There is ex-
perimental and theoretical evidence that this transporter
reversal can occur under physiological conditions (Ber-
nath and Zigmond, 1988; Richerson and Wu, 2003; Wu
et al., 2003). Our results should also not be surprising
given the direct demonstration that GABA transporter
reversal can mediate GABAergic neurotransmission be-Ntween fish retinal neurons (Schwartz, 1987), and evidence
that a similar phenomenon occurs in the rabbit retina
(O’Malley et al., 1992). Reversal of the dopamine trans-
porter, which has a similar stoichiometry, has also been
shown to support communication between neurons in
the substantia nigra (Falkenburger et al., 2001). Thus,
the phenomenon we demonstrate here is expected from
a theoretical viewpoint, in context with the existing litera-
ture and in light of our new data from CHO cells.
GABA transporters are widely believed to operate
slowly (Mager et al., 1993). However, recent data indicate
that the turnover rate for GAT-1 is faster than previously
believed, taking 66 ms per translocation cycle at 21C
and 11 ms per translocation cycle at 37C (Gonzales
et al., 2007). However, this would still be too long for
a complete cycle to occur during an action potential that
lasts only a few milliseconds. Therefore, depolarization
may lead to GABA release from GAT-1 molecules that
have already undergone voltage-independent transitions
between states prior to depolarization. Alternatively, it is
not known how long it takes to complete each step in
a translocation cycle, and it is possible that GAT-1 may
release GABA rapidly in response to depolarization by
completing only a subset of steps in a cycle. In the future
it will be important to directly address questions such
as this about the molecular dynamics of the release
process.
Relevance to Neurotransmission In Vivo
Our results from neurons were obtained in cell culture, and
it is not clear whether GABA transporter reversal would
also occur in vivo. If GAT-1 reversal does not occur
normally, it is possible that it is enhanced under some con-
ditions in vivo. For example, during seizures, depolariza-
tion and increased intracellular [Na+] during bursts would
both enhance GAT-1 reversal, consistent with direct
measurements of GABA release in the human temporal
lobe using microdialysis (During et al., 1995). In dentate
granule cells, kainic acid-induced seizures lead to an in-
crease in expression of glutamic acid decarboxylase and
GAT-1 (Sperk et al., 2003), which would both also enhance
GAT-1-mediated GABA release.
Our results may overestimate the contribution of nonve-
sicular release, because vesicular release was blocked in
our experimental paradigm, and GAT-1-mediated GABA
release is not independent of vesicular GABA release.
When vesicular release occurs, it would be less likely
that GAT-1 would reverse, because the increase in extra-
cellular [GABA] due to vesicular release would increase
the inward gradient for GABA transport, as predicted by
theoretical calculations (Richerson and Wu, 2003). In this
case, our results can be interpreted as indicating that
there would be a reduction in the driving force for GABA
uptake during neuronal firing, rather than frank reversal.
This could explain why blocking GABA transporters
does not always lead to an increase in amplitude or dura-
tion of IPSPs (Dingledine and Korn, 1985; Isaacson et al.,
1993; Nusser and Mody, 2002).euron 56, 851–865, December 6, 2007 ª2007 Elsevier Inc. 861
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the behavior of GAT-1 at synaptic versus extrasynaptic
sites. Synaptic and perisynaptic GAT-1 may not reverse
as easily in vivo due to coexisting vesicular GABA release.
However, our results may be particularly relevant to the
behavior of extrasynaptic GAT-1. As neuronal firing in-
creases there would be an increase in the extrasynaptic
[GABA] at which GAT-1 is at equilibrium, which would be
predicted to increase tonic inhibition.
Conclusions
The results described here indicate that GAT-1, in addition
to recovering extracellular GABA after vesicular release,
plays an important role in regulating the level of tonic inhi-
bition by attempting to clamp ambient [GABA] at a rela-
tively high level. Our findings also indicate that GAT-1 is
highly dynamic, being capable of changing direction rap-
idly and frequently. Nonvesicular GABAergic neurotrans-
mission may be a primitive form of synaptic communica-
tion that is complementary to vesicular fusion and has
been retained as a fail-safe release mechanism in the
mammalian CNS. This feature of the GABAergic system,
which is not shared by the glutamatergic system, may
play a critical role in maintaining inhibition during high-
frequency firing when vesicular fusion begins to fail, acting
as a brake to prevent runaway excitation. Nonvesicular
GABA release, which is increased by two novel anticon-
vulsants, gabapentin (Cheng et al., 2006; Honmou et al.,
1995) and vigabatrin (Wu et al., 2001, 2003), may play
a critical role in control of brain excitability and may be
a new target for physiological and pharmacological mod-
ulation (Deken et al., 2001; Whitworth and Quick, 2001).
EXPERIMENTAL PROCEDURES
CHO Cell Transfection
Chinese hamster ovary cells (CHO cells) were grown in Iscoves’s mod-
ified Dulbecco’s medium supplemented with 10% fetal bovine serum,
sodium hypoxanthine, thymidine, and penicillin/streptomycin (all from
Invitrogen). Cells were split when they were confluent and plated onto
glass coverslips in 12-well Falcon plates 1 or 2 days before transfec-
tion. Transfection was performed using lipofectamine (4 ml/well; Life
Technologies).
Rat GAT-1 (Slc6a1) cDNA was subcloned into a pIRES2-EGFP vec-
tor (Clontech) and transfected using 1.6 mg of DNA per well. Rat GABAA
receptor a6 subunit (Gabra6) cDNA was subcloned into a pIRES2-
EGFP vector. Rat b3 (Gabrb3) and d (Gabrd) subunit cDNAs were
subcloned in a pCMV vector. For transfection of GABA receptors, a to-
tal of 2.87 mg of DNA was used per well, in a ratio of 1 a6:2 b3:2 d. This
ratio was used to increase the chance that every green cell (those ex-
pressing the a6 subunit) also expressed b3 and d subunits.
Cell Culture
Primary cell cultures of hippocampal neurons and glia were prepared
from neonatal (P0-P2) Sprague-Dawley rats as described previously
(Gaspary et al., 1998; Wu et al., 2001, 2003). Culture wells were supple-
mented with culture medium to which vigabatrin, tetanus toxin, or
concanamycin A were added in the appropriate concentration (using
a 10–1003 stock), and then maintained in an incubator until recording.
All culture experiments were performed on neurons pretreated with
100 mM vigabatrin (usually for 3–5 days), with three exceptions: (1)862 Neuron 56, 851–865, December 6, 2007 ª2007 Elsevier Inccomparing IPSCs with and without vigabatrin treatment; (2) measuring




One day after transfection, two coverslips were placed in a recording
chamber mounted on the stage of an inverted light microscope (Axio-
vert 100, Zeiss), one with CHO cells transfected with GAT-1 and the
other with CHO cells transfected with GABAA receptors. The recording
chamber was irrigated at 2–3 ml/min with Ringer (in mM): NaCl 124,
KCl 3, CaCl2 2, MgCl2 2, NaHCO3 26, NaH2PO4 1.3, dextrose 10; pH
7.4 after bubbling with 95% O2/5% CO2. Transfected cells were iden-
tified by visualizing GFP fluorescence. The bath solution for individual
experiments was modified from that described above, as indicated in
the text. All experiments were performed at room temperature.
Patch-clamp recording electrodes (1.4–3.0 MU) were fabricated
from thin-walled, borosilicate glass tubing with a micropipette puller
(Sutter Instruments, Model P-87, Novato, CA). Whole-cell patch-clamp
recordings were made from GAT-1 cells with an electrode solution that
contained various concentrations of Na+, Cl, and GABA as indicated.
For example, the control solution with 15 mM Na+, 10 mM Cl, and
2 mM GABA contained (in mM) NaCl 10, NaOH 5, KOH 115, methane-
sulfonic acid 120, GABA 2, N-[2-hydroxyethyl]piperazine-N0-[2-etha-
nesulfonic acid] (HEPES) 10, ethylene glycol-bis (b-aminoethyl
ether)-N,N,N0,N0-tetraacetic acid (EGTA) 1, (pH adjusted to 7.2 with
KOH). Changes in [Na+] were made by adjusting the concentrations
of NaCl, NaOH, KOH, and/or KCl to maintain constant [Cl] and osmo-
larity. Changes in [Cl] were made by adjusting the concentrations of
NaCl, NaOH, KOH, KCl, and/or methanesulfonic acid to maintain con-
stant [Na+], [K+], and osmolarity. When changes in [GABA] were made,
the concentrations of KOH and methanesulfonic acid were adjusted to
maintain constant osmolarity. The GAT-1 cell was lifted off its coverslip
and moved over to the other coverslip to touch a CHO cell transfected
with GABAA receptors. A second whole-cell patch-clamp recording
was made from the sniffer cell with an electrode solution that contained
(in mM) KCl 135, HEPES 10, EGTA 1 (KOH to pH 7.2). This resulted in
a Nernst potential for Cl of 0 mV.
Patch-clamp recordings were made using a MultiClamp 700A ampli-
fier (Axon Instruments, Foster City, CA). Recordings were filtered,
digitized, and stored on computer using a commercially available
data acquisition system (Digidata 1322A and PClamp software, Axon
Instruments). Recordings from both CHO cells were made in volt-
age-clamp mode at a holding potential of 60 mV. Voltage steps
and voltage ramps (as described) were induced in the GAT-1 cell to de-
termine the voltage dependence of GAT-1-mediated GABA release.
For the experiments shown in Figure 3C, the voltage-clamp command
supplied to the patch-clamp amplifier was derived from a data file ob-
tained from a current-clamp recording of action potentials in a cultured
neuron. Steady-state currents induced in sniffer cells were quantified
using Clampfit software (Axon Instruments).
Paired Hippocampal Neurons
For recordings from neurons, coverslips were placed in a chamber on
a fixed stage upright light microscope (Axioskop FS, Carl Zeiss) and
superfused (at 3–4 ml/min) with one of the following solutions. Ringer
contained (in mM) NaCl 124, KCl 3, MgCl2 2, CaCl2 2, NaH2PO4 1.3,
NaHCO3 26, dextrose 10, the GABAB receptor antagonist CGP-
55845 (1 mM), and the glutamate receptor antagonists 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; 10 mM), and (±)-2-amino-5-phos-
phonopentanoic acid (AP-5; 50 mM). High Mg2+/low Ca2+ Ringer was
the same solution (including receptor antagonists) except CaCl2 was
reduced to 0.2 mM, MgCl2 was increased to 10 mM, NaCl was reduced
to 117 mM, and KCl was reduced to 1 mM. Zero calcium solution was
the same as Ringer, except that CaCl2 was omitted and 1 mM EGTA
was added. For some experiments with zero calcium solution, kynur-
enic acid (1 mM) was substituted for CNQX and AP-5. Bath solutions
were bubbled with 5% CO2/95% O2 at pH 7.4. For a small number.
Neuron
Nonvesicular Neurotransmission via GAT-1 Reversalof experiments (Figure 7F), a pressure microejection system was used
to apply zero calcium Ringer modified to increase KCl to 9 mM and de-
crease NaCl to 118 mM. All experiments were performed at room tem-
perature.
Whole-cell patch-clamp recordings were made from two neurons
using either two Axopatch 1D amplifiers or a MultiClamp 700A ampli-
fier (Axon Instruments). Recordings were first made in normal Ringer to
identify neuron pairs in which stimulation of one induced a GABAergic
IPSC in the other. The bath solution was then switched to one of the
other solutions described above. Identification of presynaptic GA-
BAergic neurons was initially performed by trial and error. Later, the
yield of useful recordings was increased by choosing neurons based
on morphology. The postsynaptic neuron was recorded in voltage-
clamp mode at a holding potential of 50 mV. The presynaptic neuron
was recorded in current-clamp mode and stimulated (50 Hz, 9–20 s)
with sufficient current to insure that each stimulus induced an action
potential. Recordings were filtered, digitized, and stored on computer
using a commercially available data acquisition system (TL-1 DMA or
Digidata 1322A, and PClamp software, Axon Instruments). Recording
electrodes (2.5–4.0 MU) were fabricated from thin-walled, borosilicate
glass tubing (Diamond General, Ann Arbor, MI). For most experiments,
patch-clamp electrodes were filled with solution containing (in mM)
methanesulfonic acid 135, KOH 130, KCl 2, HEPES 5, EGTA 1,
NaOH 5, and GABA 5. In a small number of recordings, NaOH and
GABA were decreased to 0 mM each or increased to 20 mM each
(KOH and methanesulfonic acid were adjusted to maintain osmolarity).
These recordings gave the same general results and contributed to the
‘‘n’’ values, but these data were not included in the quantitative analy-
ses. For the zero calcium experiments presented in Figure 7, the pre-
synaptic electrode contained (in mM) NaCl 10, NaOH 5, KOH 115,
methanesulfonic acid 120, HEPES 10, EGTA 1, and GABA 5. The post-
synaptic electrode contained (in mM) QX-314 10, CsCl 124, HEPES 10,
and EGTA 10. This solution caused GABAA receptor-mediated cur-
rents to be inward instead of outward. Electrode solutions were ad-
justed to pH 7.2 with KOH or CsOH and to an osmolarity of 270 ± 5
mOsm with dH2O. Initial seal resistance was R1 GU. Whole-cell ac-
cess was typically 10–20 MU. Although we used whole-cell recordings
and this could potentially influence the driving force for GAT-1 reversal,
we found that the composition of the solution in the whole-cell record-
ing pipette used for the presynaptic neuron had no effect on IPSCs,
even when [Na+] and [GABA] were elevated to high levels. This was
probably because GABA and Na+ within the soma were not able to dif-
fuse to distant presynaptic terminals.
Data Analysis
Measurement of Reversal Potential Using Ramp Protocols
To measure the reversal potential of GAT-1, we used voltage-clamp
recordings from sniffer cells to measure the current induced in re-
sponse to ramp depolarization of a GAT-1 cell as shown in Figure 2A.
An individual blind to the calculation of the reversal potential drew
a horizontal line through the flat portion of the moving average. A ver-
tical line was then drawn at the first point at which the moving average
dropped below the horizontal line and did not return (i.e., when GABA
release first began to occur). There was some drift in the baseline in
some cases, but the point at which there was divergence from the
baseline could be reliably identified with consistent values obtained
on repeat analysis. The voltage at which this vertical line intersected
the voltage-clamp command trace was defined as the reversal poten-
tial for GAT-1.
Analysis of IPSCs
Data analysis was performed using either custom-written analysis
routines (OriginLab Corp, Northampton, MA) or a commercially avail-
able analysis program (Clampfit, Axon Instruments), in both cases
using signal-averaging techniques. IPSCs in high Mg2+/low Ca2+
Ringer were quantified as the integral of the baseline-subtracted cur-
rent in picocoulombs. IPSCs in normal Ringer and zero calcium Ringer
were quantified as the peak amplitude (difference between the peakNcurrent and the prestimulus baseline current) in picoamps. Steady-
state amplitude was determined as the mean amplitude for the last
2 s of an IPSC.
All values expressed as x ± y are mean ± SEM, and all error bars are
SEM.
Thermodynamic Equations Describing GAT-1
As previously described (Richerson and Wu, 2003), the equation used
to calculate the reversal potential for GAT-1 was derived by rearrang-
ing the equation for the electrochemical driving force for GAT-1 when it




















where Em = reversal potential, Zx = the valence of ion X, F = Faraday’s
constant, R = universal gas constant, and T = temperature (295K).
There is a useful website that calculates the solution to this equation
for any combination of variables at http://www.csupomona.edu/
seskandari/physiology/physiological_calculators/gat_v_rev.html.
To calculate ambient [GABA] when GAT-1 is at equilibrium (Figure 8),
we rearranged the above equation to solve for [GABA]out with mem-
brane potential as a variable.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/56/5/851/DC1/.
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